COVID-19 trials aren't the only studies that can achieve super speed

Is it possible to enroll clinical trials 10 times faster than the industry’s average speed? Elligo Health Research thinks so.

By Kelly Bilodeau • March 15, 2022

Clearing hurdles in rare cancer drug development

Rafael’s CEO, Sanjeev Luther, explains why flexibility and agility are keys to success in the rare cancer space.

By Kim Ribbink • March 14, 2022

Explore the Trendline➔

Commercialization, marketing and social media

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

By PharmaVoice staff

Biote CEO: Employers need to normalize women's health issues in the workforce

A survey by Biote reveals the impact of menopause on working women.

By Robin Robinson • March 14, 2022

Woman of the Week: Genentech's Quita Highsmith

Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.

By Taren Grom • March 9, 2022

Ramona Sequeira breaks PhRMA's glass ceiling

A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.

By Taren Grom • March 7, 2022

Two key factors behind NYC's record-setting rise in healthcare funding

According to a new report, women’s and digital health led to an explosion in funding last year in NYC.

By Robin Robinson • March 7, 2022

Are patients happy? This simple question could shake up clinical trials

The migration to DCTs is helping uncover critical gaps in patient experience.

By Kelly Bilodeau • March 4, 2022

The 2022 PharmaVoice 100 — new look, same drive for excellence

Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.  

By Taren Grom • Feb. 28, 2022

Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo

Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.

By Taren Grom • Feb. 23, 2022

Home is where the trial is

Facing pandemic disruptions, smaller biotechs are discovering the benefits and challenges of turning to decentralized clinical trials. 

By Kelly Bilodeau • Feb. 7, 2022

Komodo Health's partnership with Chan Zuckerberg Initiative gives 50 rare disease patient organizations access to next-generation analytics

With 330 million patient healthcare encounters in its database, Komodo assists advocacy organizations in gaining insights on specific patient populations.

By Robin Robinson • Feb. 3, 2022

PTC's vice president of patient relations outlines the importance of patient input in rare disease R&D

You can't know what matters to rare disease patients unless you ask them.

By Kim Ribbink • Feb. 3, 2022

Woman of the Week: Google Cloud's Andrea McGonigle

Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.

By Taren Grom • Feb. 2, 2022

Woman of the Week: Syneos Health's president of commercial solutions, Michelle Keefe

How Michelle Keefe, president, commercial solutions at Syneos Health, steered her team into a rapid pivot during the pandemic.

By Taren Grom • Feb. 2, 2022

With its wealth of patient data, Walgreens is looking to disrupt the clinical trial space

How the mega-pharmacy’s clinical trials officer is looking to capitalize on its deep well of patient data to create an interconnected healthcare system of the future.

By Taren Grom • Jan. 26, 2022

Welcome to the new PharmaVoice

A similar mission, a new format, and our plans for PharmaVoice's next chapter.

By Davide Savenije • Jan. 13, 2022

Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer

Since the onset of COVID, the world has seen a radical shift by consumers to digital channels out of both safety and convenience. This shift has occurred not just for everyday goods and services like online grocery delivery and digital banking, but also with big-ticket decisions — such as 30% of ...

By Scott Snyder • Nov. 15, 2021

Data and Technology: The Key to Patient-Centric Clinical Research

A convergence of trends is transforming the trial experience and increasing efficiencies. Patient-centricity has become a driving force in clinical research. Patients expect trials to be built around their needs as a factor of participation, while regulators expect to see more diverse patient ...

By Susan Bacheller & Ann Dokus • Nov. 15, 2021

A Strong Patient Support Partnership: Balancing Technology + Talent

Improve Efficiency and Enhance Patient-Centricity Technology is growing at a fast clip in patient service hubs. Completing information online is the norm for tech-savvy patients, with automation providing speed and cost reduction. At the same time, patients require personal support to access, und...

By Karl Raabe • Nov. 15, 2021

The Rise of the Virtual Rep

For more than three decades, detailing has been one of the cornerstones of the pharmaceutical industry’s communications with physicians. Thanks to recent advances in technology, what started out as face-to-face meetings between pharmaceutical sales representatives and physicians has evolved into ...

By Ralph Greene • Nov. 15, 2021

Engaging Patients and Providers in A Digital World Utilizing Virtual Assistants and In-Workflow Services

It’s evident within our healthcare system just how challenging it can be for patients to receive information and status updates regarding their care. Portals, apps, and websites all pose challenges for patients: remembering logins, potentially missing or incomplete data, and the inability to keep...

By Ron Lacy • Nov. 15, 2021

Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli

The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...

By Clark Wooten • Nov. 15, 2021

SHOWCASE: Patient Engagement: Digital Control: Putting Solutions Into the Hands of Patients

Patient engagement solutions are key to clinician-patient interaction, improving compliance, enabling real-time reporting, and reducing visits to the doctor and hospital. Patients today want and expect to have greater control over their healthcare journey. They are accustomed to accessing informa...

By PharmaVoice Team • Oct. 1, 2021

Bridging the Patient Support Gap With Integrated Technology Solutions and Strategies

Each year, medication non-adherence causes 125,000 preventable deaths and $300 billion in avoidable healthcare costs. In a world where patients face more medication barriers than ever, patient support programs are critical in providing value-based care that yields a palpable and lasting impact. T...

By Maria Kirsch • Oct. 1, 2021

Social Health: Reinventing the Patient Journey

Welcome to the next generation of the patient journey. It’s a journey that’s no longer vaguely linear — patients are now benefiting from practically infinite human connections enabled and accelerated by digital communication. Those connections have transformed the patient journey from a path to a...

By Jack Barrette • Oct. 1, 2021